Postsynaptic 5‐hydroxytryptamine1A receptor activation increases in vivo dopamine release in rat prefrontal cortex
Open accessThe DOI matches its Crossref record.
Abstract
5‐Hydroxytryptamine (5‐HT) plays a role in the regulation of 3,4‐dihydroxyphenylethylamine (dopamine) neurons in the brain, but the precise mechanism of regulation by 5‐HT 1A receptors of dopamine release has not been defined. The present study describes the effect of 5‐{3‐[[(2S)‐1,4‐benzodioxan‐2ylmethyl]amino]propoxy}‐1,3‐benzodioxole HCl (MKC‐242), a highly potent and selective 5‐HT 1A receptor agonist, on dopamine release in the prefrontal cortex using microdialysis in the freely moving rat. Subcutaneous injection of MKC‐242 (0.3–1.0 mg kg−1) increased extracellular levels of dopamine in the prefrontal cortex. The effect of MKC‐242 in the prefrontal cortex was antagonized by pretreatment with the selective 5‐HT 1A receptor antagonist, N‐[2‐[4‐(2‐methoxyphenyl)‐1‐piperazinyl]ethyl]‐N‐(2‐pyridinyl)cyclohexanecarboxamide (WAY100635; 1 mg kg−1, i.p.). Local application of WAY100635 (10 μ M) via a microdialysis probe antagonized the effect of systemic MKC‐242 in an increasing dopamine release, and locally infused 8‐hydroxy‐2‐(di‐n‐propylamino)tetralin (10 μ M) increased dopamine release in the prefrontal cortex. MKC‐242 increased cortical dopamine release in the rats pretreated with 5,7‐dihydroxytryptamine (150 μg, i.c.v.) that caused an almost complete reduction in cortical 5‐HT content. The effect of MKC‐242 to increase dopamine release was also observed in the hippocampus, but not in the striatum or nucleus accumbens. Fluoxetine, a selective serotonin reuptake inhibitor, increased dopamine release in the prefrontal cortex, but not in the nucleus accumbens, while buspirone, a 5‐HT 1A receptor agonist, increased dopamine release in both brain regions. The present results indicate that activation of postsynaptic 5‐HT 1A receptors increases dopamine release in a brain region‐specific manner. British Journal of Pharmacology (2000) 129, 1028–1034; doi:10.1038/sj.bjp.0703139
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Serotonin receptors : their key role in drugs to treat schizophrenia
Meltzer, H. Y., Li, Z., Kaneda, Y., & Ichikawa, J. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2003.09.010 · Cited by 775
Morón, J. A., Brockington, A., Wise, R. A., Rocha, B. A., & Hope, B. T. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-02-00389.2002 · Cited by 681
“This assay allows us to dissociate changes in extracellular DA that result from altered DA clearance from changes that result from altered DA release, which can be secondary to elevations in NE or 5-HT (Pozzi et al., 1994, 1999; Matsumoto et al., 1999; Sakaue et al., 2000).”
BackgroundIchikawa, J., Ishii, H., Bonaccorso, S., Fowler, W. L., O'Laughlin, I. A., & Meltzer, H. Y. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00154.x · Cited by 494
Mechanism of Action of Atypical Antipsychotic Drugs and the Neurobiology of Schizophrenia
Horacek, J., Bubenikova-Valesova, V., Kopecek, M., Palenicek, T., Dockery, C., Mohr, P., & H??schl, C. (2006) · CNS Drugs · doi:10.2165/00023210-200620050-00004 · Cited by 461
The involvement of dopamine in the modulation of sleep and waking
Monti, J. M., & Monti, D. (2007) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2006.08.003 · Cited by 415
Serotonin and psychostimulant addiction: Focus on 5-HT1A-receptors
Müller, C. P., Carey, R. J., Huston, J. P., & De Souza Silva, M. A. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.01.001 · Cited by 302
Steketee, J. (2003) · Brain Research Reviews · doi:10.1016/s0165-0173(02)00233-3 · Cited by 293
Díaz-Mataix, L., Scorza, M. C., Bortolozzi, A., Toth, M., Celada, P., & Artigas, F. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2999-05.2005 · Cited by 285
Winstanley, C. A., Chudasama, Y., Dalley, J. W., Theobald, D. E. H., Glennon, J. C., & Robbins, T. W. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1398-x · Cited by 234
“…at D1 receptors (Consolo et al. 1996), and also with reports that both systemic and intra-mPFC administration of 8- OH-DPAT increase mPFC levels of DA (Arborelius et al. 1993; Tanda et al. 1994; Gobert 1998; Sakaue et al. 2000), an effect which is potentiated by M100907 (Ichikawa et al. 2001).”
BackgroundA test of the catecholamines hypothesis for an acute exercise–cognition interaction
McMorris, T., Collard, K., Corbett, J., Dicks, M., & Swain, J. P. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2007.11.007 · Cited by 192
The neurochemistry of waking and sleeping mental activity: the disinhibition-dopamine hypothesis
GOTTESMANN, C. (2002) · Psychiatry and Clinical Neurosciences · doi:10.1046/j.1440-1819.2002.01022.x · Cited by 69
The psychostimulant d-threo-(R,R)-methylphenidate binds as an agonist to the 5HT1A receptor
Markowitz, J. S., Markowitz, J. S., DeVane, C. L., Ramamoorthy, S., Zhu, H.-J., & Zhu, H.-J. (2009) · Die Pharmazie · doi:10.31083/ph.2009.8691 · Cited by 68
Saito, Y., Matsumoto, M., Yanagawa, Y., Hiraide, S., Inoue, S., Kubo, Y., Shimamura, K., & Togashi, H. (2013) · Synapse · doi:10.1002/syn.21621 · Cited by 26
Metadata
- Authors
- Sakaue, M., Somboonthum, P., Nishihara, B., Koyama, Y., Hashimoto, H., Baba, A., & Matsuda, T.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2000-03
- Volume
- 129
- Issue
- 5
- Pages
- 1028-1034
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2102974182
- Cited by
- 143
- References
- 0
- FWCI
- 2.94
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.